lorvotuzumab mertansine

Preferred Label : lorvotuzumab mertansine;

MeSH note : has antineoplastic activity; structure in first source;

CISMeF synonym : IMGN901;

MeSH hyponym : IMGN-901;

Is substance : O;

UNII : 0IVD6ASY0W;

Détails

Origin ID

C579429;

UMLS CUI

C2987530;

Currated CISMeF NLP mapping
- Lorvotuzumab Mertansine [NCIt concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
- maytansine [MeSH Descriptor]
Pharmacological action(s)
- Antineoplastic Agents, Immunological [MeSH Descriptor]
- antineoplastic agents, phytogenic [MeSH Descriptor]
- immunotoxins [MeSH Descriptor]
Record concept(s)
- BB-10901 [MeSH concept]
- IMGN901 [MeSH concept]
- lorvotuzumab mertansine [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Lorvotuzumab Mertansine [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients